White label ELPA - ClinicalTrials.eu

Study of Cetuximab and Avelumab for Patients with Recurrent or Metastatic Head and Neck Cancer with PD-L1 Score 1 or Higher

Recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
- Cetuximab
- Avelumab
Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

Recruiting

4 1 1 1
Investigated Drugs:
+6
Study of drug combination (capecitabine, fluorouracil, oxaliplatin, calcium folinate) to prevent cancer recurrence in patients with detectable ctDNA after rectal cancer surgery

Recruiting

3 1 1 1
Investigated Diseases:
- Rectal cancer
Investigated Drugs:
Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Ocrelizumab
- Rituximab
Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

Recruiting

2 1 1 1
Investigated Diseases:
- Medulloblastoma
Investigated Drugs:
+1
Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

Recruiting

3 1 1 1
Investigated Diseases:
- Antithrombin III deficiency
Investigated Drugs:
- Antithrombin Iii Human
- Human Plasma Derived Antithrombin
+2
Study of Taletrectinib for Patients with Advanced or Metastatic ROS1 Positive Non-Small Cell Lung Cancer

Recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer recurrent
Investigated Drugs:
- Taletrectinib
Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Nivolumab
- Pembrolizumab
Study on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes

Recruiting

3 1 1
Investigated Drugs:
- Dapagliflozin
Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

Recruiting

3 1 1 1
Investigated Drugs:
- 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
- Everolimus
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies